Description: ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Home Page: www.abiomed.com
ABMD Technical Analysis
22 Cherry Hill Drive
Danvers,
MA
01923
United States
Phone:
978 646 1400
Officers
| Name | Title |
|---|---|
| Mr. Michael R. Minogue | Chairman, CEO & Pres |
| Mr. Todd A. Trapp | Exec. VP & CFO |
| Mr. Marc A. Began | Exec. VP, Gen. Counsel & Sec. |
| Mr. Andrew J. Greenfield | Exec. VP & Chief Commercial Officer |
| Dr. David M. Weber Ph.D. | Scientific & Technology Advisor |
| Mr. Matthew T. Plano | Exec. VP of Global Operations & Integration |
| Dr. Thorsten Siess Ph.D. | Exec. VP & Chief Technology Officer |
| Ms. Ingrid Goldberg Ward | Director of Investor Relations |
| Sarah Karr | Communications Mang. |
| Mr. Michael G. Howley | VP & GM of Global Sales |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 65.3551 |
| Price-to-Book MRQ: | 11.1312 |
| Price-to-Sales TTM: | 15.9593 |
| IPO Date: | 1987-07-29 |
| Fiscal Year End: | March |
| Full Time Employees: | 2003 |